Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
- Citation:
- Blood vol 118 (15) 4053-4061
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Pharmas:
- Grants:
- U10 CA035267, U10 CA037417, N01 CA035431, U10 CA035269, CA-37404, CA-35090, CA-35195, U10 CA037404, U24 CA114740, N01 CA035119, CA-114740, U10 CA035195, CA-35103, CA-25224, CA-35113, U10 CA035101, U10 CA035113, U10 CA063849, P50 CA097274, U10 CA035431, U10 CA035119, CA-37417, CA-35269, CA-35101, U10 CA025224, P50 CA97274, U10 CA035090, CA-35267, CA-63849, U10 CA035103
- Corr. Author:
- Authors:
- Ivana N. M. Micallef Matthew J. Maurer Gregory A. Wiseman Daniel A. Nikcevich Paul J. Kurtin Michael W. Cannon Domingo G. Perez Gamini S. Soori Brian K. Link Thomas M. Habermann Thomas E. Witzig
- Networks:
- Study
- NCCTG-N0489
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Clinical Trials and Observations, Lymphoid Neoplasia